Lisi Balance Sheet Health
Financial Health criteria checks 4/6
Lisi has a total shareholder equity of €967.3M and total debt of €589.7M, which brings its debt-to-equity ratio to 61%. Its total assets and total liabilities are €2.2B and €1.2B respectively. Lisi's EBIT is €107.7M making its interest coverage ratio 4. It has cash and short-term investments of €151.5M.
Key information
61.0%
Debt to equity ratio
€589.67m
Debt
Interest coverage ratio | 4x |
Cash | €151.54m |
Equity | €967.28m |
Total liabilities | €1.21b |
Total assets | €2.18b |
Recent financial health updates
These 4 Measures Indicate That Lisi (EPA:FII) Is Using Debt Extensively
Sep 13Is Lisi (EPA:FII) Using Too Much Debt?
Jun 11Is Lisi (EPA:FII) Using Too Much Debt?
Oct 06Lisi (EPA:FII) Has A Rock Solid Balance Sheet
Jun 10Lisi (EPA:FII) Has A Pretty Healthy Balance Sheet
Aug 06Is Lisi (EPA:FII) Using Too Much Debt?
Apr 06Recent updates
Is There Now An Opportunity In Lisi S.A. (EPA:FII)?
Oct 26Capital Allocation Trends At Lisi (EPA:FII) Aren't Ideal
Oct 12Lisi S.A.'s (EPA:FII) P/E Is On The Mark
Sep 27These 4 Measures Indicate That Lisi (EPA:FII) Is Using Debt Extensively
Sep 13Lisi S.A. (EPA:FII) Half-Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Jul 28Is Lisi (EPA:FII) Using Too Much Debt?
Jun 11At €27.80, Is It Time To Put Lisi S.A. (EPA:FII) On Your Watch List?
May 28Lisi's (EPA:FII) Returns On Capital Not Reflecting Well On The Business
May 11Lisi's (EPA:FII) Dividend Will Be Increased To €0.31
Apr 26Lisi (EPA:FII) Is Increasing Its Dividend To €0.31
Mar 21Lisi S.A. Just Missed EPS By 27%: Here's What Analysts Think Will Happen Next
Feb 25Lisi's (EPA:FII) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Feb 07An Intrinsic Calculation For Lisi S.A. (EPA:FII) Suggests It's 37% Undervalued
Jan 10What Does Lisi S.A.'s (EPA:FII) Share Price Indicate?
Dec 09Is Lisi (EPA:FII) Using Too Much Debt?
Oct 06At €22.65, Is It Time To Put Lisi S.A. (EPA:FII) On Your Watch List?
Aug 08The Returns On Capital At Lisi (EPA:FII) Don't Inspire Confidence
Jun 30Lisi (EPA:FII) Has A Rock Solid Balance Sheet
Jun 10Should You Investigate Lisi S.A. (EPA:FII) At €26.10?
May 05Lisi S.A. (EPA:FII) Shares Could Be 43% Below Their Intrinsic Value Estimate
Mar 01Is It Time To Consider Buying Lisi S.A. (EPA:FII)?
Feb 02Lisi's (EPA:FII) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Dec 07Is Lisi S.A. (EPA:FII) Trading At A 49% Discount?
Nov 10Returns On Capital At Lisi (EPA:FII) Paint A Concerning Picture
Sep 03Lisi (EPA:FII) Has A Pretty Healthy Balance Sheet
Aug 06Returns On Capital Signal Tricky Times Ahead For Lisi (EPA:FII)
Jun 04Is Lisi (EPA:FII) Using Too Much Debt?
Apr 06Be Wary Of Lisi (EPA:FII) And Its Returns On Capital
Feb 09These 4 Measures Indicate That Lisi (EPA:FII) Is Using Debt Reasonably Well
Nov 06Lisi (EPA:FII) Has Some Difficulty Using Its Capital Effectively
Sep 30Is Lisi (EPA:FII) Using Too Much Debt?
Jun 27The Returns On Capital At Lisi (EPA:FII) Don't Inspire Confidence
May 31An Intrinsic Calculation For Lisi S.A. (EPA:FII) Suggests It's 23% Undervalued
Apr 04Lisi (EPA:FII) Takes On Some Risk With Its Use Of Debt
Mar 08What Do The Returns On Capital At Lisi (EPA:FII) Tell Us?
Feb 08Should You Use Lisi's (EPA:FII) Statutory Earnings To Analyse It?
Jan 18Lisi S.A. (EPA:FII) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Jan 03Is There An Opportunity With Lisi S.A.'s (EPA:FII) 34% Undervaluation?
Dec 19These 4 Measures Indicate That Lisi (EPA:FII) Is Using Debt Reasonably Well
Dec 07A Quick Analysis On Lisi's (EPA:FII) CEO Salary
Nov 23Will Lisi (EPA:FII) Multiply In Value Going Forward?
Jul 17Would Lisi S.A. (EPA:FII) Be Valuable To Income Investors?
Jul 05Financial Position Analysis
Short Term Liabilities: FII's short term assets (€921.5M) exceed its short term liabilities (€583.4M).
Long Term Liabilities: FII's short term assets (€921.5M) exceed its long term liabilities (€629.8M).
Debt to Equity History and Analysis
Debt Level: FII's net debt to equity ratio (45.3%) is considered high.
Reducing Debt: FII's debt to equity ratio has increased from 53.6% to 61% over the past 5 years.
Debt Coverage: FII's debt is well covered by operating cash flow (30.6%).
Interest Coverage: FII's interest payments on its debt are well covered by EBIT (4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 04:25 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lisi S.A. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Geoffrey d'Halluin | BNP Paribas Exane |
Carole Rozen | CA Cheuvreux |
Hervé Drouet | CIC Market Solutions (ESN) |